INTRODUCTION
Senescence is a form of cell-cycle arrest first identified in cells at the end of their replicative lifespan (Hayflick, 1965) . Subsequently, it was demonstrated that senescence could be induced prematurely by oncogenes in primary cells, inducing oncogeneinduced senescence (OIS) (Serrano et al., 1997) . This was followed by the discovery in adult cells of other senescenceinducing stimuli, including DNA damage, oxidative stress, and chemotherapeutic drugs (Kuilman et al., 2010; Narita et al., 2003; Schmitt et al., 2002) .
Senescent cells usually share a combination of signature features, including a characteristic, enlarged, and flat morphology.
Primarily, they are nonproliferating, exhibit activation of senescence-associated beta-galactosidase (SAb-gal) activity, and have enhanced expression of hallmark regulatory proteins (Dimri et al., 1995; Kuilman et al., 2010) . Among the key proteins that are induced are members of the p53/p21 and p16/RB tumorsuppressor networks that function to arrest proliferation and contribute to the irreversibility of the senescent state (Narita et al., 2003; Serrano et al., 1997) . This involvement of tumorsuppressor pathways led to the identification of senescence as a potent tumor-suppressor mechanism in vivo (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005) . More recently, however, broader roles for senescence in nontumorigenic pathologies are emerging. Senescent cells are suggested to increase in number with age and to contribute significantly to age-related decline (Baker et al., 2011; Dimri et al., 1995) . Senescent cells also contribute to the process of liver fibrosis and wound repair (Jun and Lau, 2010; Krizhanovsky et al., 2008) . However, to date, senescence has not been described in nonpathologic states.
An emerging hallmark feature of senescent cells is the senescence-associated secretory phenotype (SASP) that allows extensive signaling from the nonproliferating cells to the external environment (Acosta et al., 2008; Coppé et al., 2010; Kuilman et al., 2008 Kuilman et al., , 2010 . This secretome is largely composed of growth factors, cytokines/chemokines, and extracellular-matrix-remodeling proteins secreted by the arrested cells (Freund et al., 2010) . Some of these secreted factors have functional roles compatible with senescence, such as the reinforcement of the arrested state (Acosta et al., 2008; Kuilman et al., 2008) or the recruitment of immune cells to remove senescent cells (Xue et al., 2007) . However, there are paradoxical aspects of the SASP and senescence that argue against a sole tumor-suppressive role. In some instances, the SASP can induce proliferation or epithelial-tomesenchymal transformation (EMT) and invasion in neighboring cells, exerting protumorigenic influence (Krtolica et al., 2001; Parrinello et al., 2005) . In others, senescent cells instruct angiogenesis and vessel patterning (Coppé et al., 2006) or alter the local environment with the production of matrix-remodeling factors (Coppé et al., 2008; Parrinello et al., 2005) . In addition, senescent cells are resistant to apoptotic stimuli, a finding at odds with their tumor-suppressive role (Mooi and Peeper, 2006; Wang, 1995) .
In many ways, as a distinct cellular process, senescence can be equated to apoptosis, a tumor-suppressive mechanism that acts to functionally remove cells at risk of aberrant growth. In addition, both processes have demonstrated roles in tissue pathology and repair. Given that apoptosis also has critical functions during normal embryonic development, we asked whether senescence might also play a role in the embryo. Surprisingly, we found that senescent cells are detectable in many different tissues and locations throughout the embryo, including known signaling centers. We describe that senescence is a normal programmed component of embryonic development and uncover a role in tissue development and patterning.
RESULTS

Senescent Cells Are Widespread throughout the Developing Embryo
To investigate whether senescence is expressed in the developing embryo, we used whole-mount staining for SAb-gal activity. We had previously demonstrated that this approach identifies senescent cells in a model where senescence was activated prematurely (Keyes et al., 2005) . Embryos at mid to late stages of development (embryonic days [E] 9.5-17.5) were stained with SAb-gal and were examined for the appearance of positively staining cells. Surprisingly, distinct regions were immediately visible (Figure 1) , and it was clear these were specific anatomical structures and locations throughout the embryo. Examples of positive areas included the developing limbs (Figures 1A and 1B) , the tip of the tail ( Figure 1C ), the otic vesicle (Figure 1D) , the brain vesicles ( Figure 1E ), the closing neural tube ( Figure 1F ), the fusing sternum midline, and the gut endoderm (Table S1 and Figure S1A available online). Sectioning of these embryos that had been stained with SAb-gal further identified specific stained populations of cells and tissues ( Figure S1A) . Interestingly, the staining in each location was detectable in 100% of animals but was only detectable during a specific time window, with all senescence detectable in this manner disappearing by E17.5 (sites and timeline are detailed in Table S1 ). Staining with SAb-gal identifies senescent cells at acidic pH 5.5. To support that the staining in the embryo indicated senescence, we stained embryos at pH 6.5 and 7.0. In each case, no staining was detectable, validating the senescent phenotype of the positive cells ( Figure S1B ). To further investigate these findings, we tested to see whether SAb-gal was detectable in chick embryos. Interestingly, similar distinct patterns of staining were visible throughout the embryo, including at the limbs, in the pharyngeal arches ( Figure 1G ), along the closed neural tube/spinal column ( Figure 1H ), and in the developing eye ( Figure 1I ). Together, this identifies that SAb-gal staining is found in distinct structures and tissues during particular time windows in the normal developing embryo.
Embryonic Structures Express Molecular Mediators of Senescence
To verify that SAb-gal indicated senescence, we examined for expression of known markers and mediators of senescence in two separate tissues that presented with pronounced SAb-gal at E11.5. Senescence in the limb appeared as a distinct layer around the edge of the developing limb bud in a pattern reminiscent of the apical ectodermal ridge (AER) (Figure 2A ). The AER is a zone of specialized ectoderm marking the dorsoventral boundary of the limb bud and is a major signaling center regulating limb Table S1 . OV: otic vesicle, HL: hindlimb, FL: forelimb, LH: left hemisphere, RH: right hemisphere, NT: neural tube, PA: pharyngeal arch. See also Figure S1 and Table S1 . outgrowth and patterning (Cohn et al., 1995; Niswander et al., 1993) . It lies directly above and, via secreted growth factors including fibroblast growth factors (FGFs), instructs the progress zone (PZ), an area of mesenchymal proliferation at the tip of the limb. In turn, the PZ is reciprocally required to maintain AER function (Kanegae et al., 1998) . The AER can be identified with in situ hybridization for FGF8, which develops in a pattern of expression that exactly matches that of SAb-gal ( Figure 2A) .
Sectioning of the whole-mount SAb-gal-stained embryos confirmed that the AER stains positive for senescence. Next, we tested for the expression of known senescence markers, including p53, p21, p16, p19, PML, gH2AX, and H3K9me3, as well as the ability to incorporate BrdU. Interestingly the cells of the AER were nonproliferative and expressed high levels of p21, but not p53 (Figure 2A ), whereas the adjacent zone of proliferative mesenchyme was negative for these senescence markers. In addition, the AER expressed PML and H3K9me3 ( Figure S2A ) but at levels similar to the those of proliferating mesenchymal cells, whereas p16 (not shown) and p19 expression were not detectable in the limb.
To identify whether similar results were seen in other regions of the embryo, we looked at the closing neural tube, where a line of senescent cells was visible (Figures 1F and 2B) . Transverse sections of SAb-gal-stained E11.5 embryos identified a narrow band of epithelial cells, the roof plate (RP) of the hindbrain, that were stained with SAb-gal ( Figure 2B ). The RP is another signaling center that instructs central nervous system (CNS) cell fate, induces neural crest activity, and contributes to blood vessel patterning along the embryonic axis (Chizhikov and Millen, 2004; Gammill and Bronner-Fraser, 2003; Lee et al., 2000) . Analysis of senescence markers confirmed that these cells are also nonproliferative and express high levels of p21 but do not have detectable levels of p53, p16 (not shown), or p19 (Figures 2B and S2B) . Interestingly, in the chick, this structure expresses the transcript for p15, another key regulator of senescence (Kim et al., 2006) . Together, this identifies that two major signaling centers in the embryo contain senescent cells.
The AER Shares an Expression Signature with OIS
We wanted to assess whether these structures expressed any other markers of senescence or shared similarity with OIS. As a first step, we performed gene-expression profiling on the AER. The AER was microdissected from E11.5 mouse forelimbs, and pooled replicates were compared to samples of nonsenescent surface ectoderm from the dorsal-proximal limb bud (Figure 3A) . Importantly, many known AER genes, including FGF8 and 4, Msh homeobox (MSX) 1 and 2, distal-less homeobox Table S2 , along with the AER expression values for the genes common to OIS and AER. Underlying graphs represent GO analysis of upregulated genes common to senescence and development (left), downregulated genes ( Figure S3 ), and genes in OIS (right). (C) qPCR validation on separate biological replicates for selected genes identified in the microarray. Values are expressed as mean ± SEM. Ecto, Ectoderm; AER, apical ectodermal ridge. See also Figure S3 and Table S2. (DLX) 1 and 2, and R-Spondin 2 (RSPO2), were among the most highly detected ( Figure 3A ), validating that this is an AER-enriched gene-expression profile. We used real-time quantitative polymerase chain reaction (qPCR) for FGF8 and FGF4 genes to validate these results on separate biological samples ( Figure 3A) .
Next, we used published data sets to retrieve gene-expression signatures of senescent cells. Collado et al. (2005;  GEO accession number GSE2487) profiled senescent IMR90 human fibroblasts induced into OIS (Collado et al., 2005) . This study provides two separate profiles of senescent cells, which we merged to extract a representative gene-expression signature of senescence induced by oncogenic stimulation. This was then overlapped with the signature of the AER-enriched genes to identify those unique to each state and those genes common to both the AER and OIS ( Figure 3B and Table S2) . Surprisingly, from 546 AER-enriched genes that were common to both studies, 50% (271 genes; p = 0.029; Fishers enrichment test) exhibited increased expression in senescent human fibroblasts ( Figure 3B and Table S2 ), whereas 60% (273 genes; p = 0.0004; Fishers enrichment test) of the downregulated genes also overlapped ( Figure S3A) . Interestingly, among the upregulated genes common to both senescent human fibroblasts and the AER were the senescence inducers p21 (CDKN1A) and p15 (CDKN2B) ( Figure 3B ). However, many other genes that were previously implicated in the regulation of senescence and the SASP, such as CCAAT/ enhancer-binding protein beta (CEBP/B), insulin-like growth factor-binding protein 5 (IGFBP5), wingless-type MMTV integration site family, member 5A (WNT5A), and the macrophagerecruiting factors colony-stimulating factor 1 (CSF1) and CD44, were also increased in the AER. Gene Ontology (GO) analysis of the signature common to the AER and OIS highlights the developmental profile of the genes that are up-and downregulated ( Figures 3B and S3 ). The increased expression in the AER for a number of these common genes was confirmed by qPCR on separate biological samples ( Figure 3C ). In addition, we used the embryonic midline, another site of in vivo senescence, to validate expression of some senescence markers. Interestingly, in this tissue, p15 was also prominently expressed ( Figure S3B ), suggesting that it might be a common regulator of developmental senescence.
Furthermore, among the genes that were expressed in the AER but did not overlap with this profile of OIS were other mediators of senescence, including Retinoblastoma (RB1), B-Raf protooncogene serine/threonine-protein kinase (BRAF), checkpoint kinase 2 (CHEK2), and activating transcription factor 2 (ATF2) (Figure 3B) . Together, this identifies that the AER shares a significant gene-expression signature with OIS, in particular expressing critical mediators of the senescence program and the SASP.
However, it was striking to also note that in OIS, there was a strong expression of genes that comprise many well-known developmental pathways ( Figure 3B ). Indeed, we used GO analysis on the OIS signature to identify biological processes that are altered in senescent cells. Surprisingly, this identified that many developmental processes are among the main signatures and pathways of the genes that change expression ( Figure 3B ). This identifies that the induction of OIS involves changes in expression of many different developmental pathways.
p21-Deficient Mice Exhibit Alterations in Senescence and Limb Patterning
As a first step toward identifying a possible role for senescence in the embryo, we examined mouse models that are genetically deficient in known senescence mediators. We identified p21 as a common marker of senescent cells in the developing embryo and OIS. Although mice deficient in p21 are described as being developmentally normal (Brugarolas et al., 1995; Deng et al., 1995) , we sought to examine this more closely and assess whether p21 deficiency might cause defects in embryonic senescence. Initially, we subjected p21-deficient mice at E11.5 to whole-embryo SAb-gal staining. Interestingly, we noticed that these mice had a significant reduction in the total number of SAb-gal-positive cells in the AER ( Figure 4A ). In addition to inhibiting the cell cycle, a major function of p21 is to prevent apoptosis. To identify the impact of p21 deficiency and impaired senescence, we looked for changes in proliferation or cell death. Surprisingly, we found a significant increase in cell death in the SAb-gal-positive cells of the AER as measured by TUNEL staining ( Figure 4B ), suggesting that in the absence of p21, these cells adopted a fate of cell death. Interestingly, there was no difference in the rate of proliferation in the AER in the absence of p21 ( Figure 4C ). However, there was a significant decrease in proliferation in the mesenchyme directly below the AER, suggesting that the function of the AER in promoting proliferation in the underlying tissue was impaired as a result of impaired senescence ( Figure 4C, right graph) .
To extend this analysis and to determine whether loss of senescence in p21-deficient mice might affect the integrity and function of the AER, we assayed for FGF expression. Interestingly, in the AER, these mice exhibited decreased expression of FGF8 and FGF4, two key proliferation-inducing signals from the AER to the mesenchyme and limb ( Figure 4D ) (Capdevila and Izpisú a Belmonte, 2001; Sun et al., 2002) . This suggests that the function of the AER in instructing pattern formation and proliferation to the mesenchyme might be compromised in p21-deficient animals. To evaluate this, we dissected the PZ from limbs at E11.5 and performed qPCR for known patterning genes ( Figure 4E ). Interestingly, p21-deficient mice had a significant disruption of the normal pattern for many of these genes, including GLI3, MSX2, MEIS1, and SHH, and a decrease in the proliferation marker KI67 ( Figure 4E ; unmerged graphs of biological replicates in Figure S4 ). Together, these data demonstrate that p21 is required for normal senescence and patterning in the limb.
Interestingly, p21 directly regulates the expression of some SASP components (Chang et al., 2000; Devgan et al., 2006) . To ask whether p21 might also regulate developmental patterning genes in OIS, we used the tissue culture model of OIS induced in IMR90 human fibroblasts. In these cells, we used small interfering RNA (siRNA) to knock down p21 levels in senescent cells and, as proof-of-principle, assayed for the expression of some of the developmental patterning genes that were identified in OIS ( Figures 4F and S4C) . Interestingly, we found that a deficiency of p21 directly in senescent cells significantly disrupted the pattern of expression of select developmental mediators. Together, this suggests that p21 is a critical mediator of developmental senescence, and that these functions might be partially conserved in OIS.
Senescence Overlaps with the Pattern of the AER In the embryo, we identified that developmental senescence appears during particular time windows but disappears before birth. To identify the ultimate fate of embryonic senescent cells, we performed a time-course staining on the limb. During development, the limb bud develops from reciprocal signaling between the ectoderm and underlying mesenchyme to initiate outgrowth at E9.5 (Capdevila and Izpisú a Belmonte, 2001 ). Limb development proceeds through well-defined stages to reach the state of a mature appendage by E17.5. We examined the developing limb for SAb-gal staining at each stage. Staining was visible in the distal tip of the initiating limb bud at E9.5 (Figure 5A) . By E10.5-11.5, the pattern of senescence became restricted to the tip of the limb in the developing AER ( Figures  5B and 5C ). The AER is a transient structure that persists until later stages of development, before ingressing into the interdigital spaces (Guo et al., 2003) . Interestingly, the pattern of staining with SAb-gal seemed to very closely follow that of the AER, with staining persisting through E12.5 and E13.5 ( Figures  5D and 5E ). By E13.5, senescent cells were apparent in the developing interdigital spaces, and by E14.5, following disappearance of most of the interdigital tissue, senescence staining was prominent on the posterior flanks of the digits ( Figure 5F ). By E15.5, staining had virtually disappeared, with only small focal regions remaining on the tips of the developing nails (Figure 5G) , and was no longer detectable by E16.5-17.5 (Figures 5H and 5I). In addition, a similar pattern of expression and timing was seen in the AER of developing chick wing bud (Figure S5) . Altogether, this demonstrates that senescent cells and the AER follow the same pattern and distribution during a precise developmental window.
Senescent Cells in the Limb Are Removed by Apoptosis and Immune-Mediated Clearance
In stress-induced senescence, senescent cells are removed by immune-mediated clearance (Kang et al., 2011; Xue et al., 2007) . In the embryo, the AER is removed by apoptosis and macrophage-mediated phagocytosis (Guo et al., 2003; Wood et al., 2000) . To uncover the cause of senescence disappearance in the limb, we sectioned limbs from embryos at E11.5-14.5 that had been whole-mount stained for SAb-gal. At the histological level, the redistribution of the pattern of senescent cells was clearly visible. At E11.5-12.5, senescent cells were largely detectable in the ectoderm of the AER (Figures 6A, 6B , and 6E). However, by E13.5, there were fewer positive cells in the surface ectoderm/AER, and the remaining senescent cells were predominantly detected in the adjacent mesenchyme (Figures 6C and 6E) . By E14.5, senescent cells had practically disappeared from the digit ectoderm ( Figures 6D and 6E) , and the remaining cells were predominantly in the posterior mesenchyme. Interestingly, once senescent cells appeared in the mesenchyme, they were frequently surrounded by clusters of immune cells ( Figures 6C and 6D , II 0 -III 0 ). Immunostaining for the macrophage marker F4/80 revealed that, consistent with previous reports (Wood et al., 2000) , there is an infiltration of macrophages in the developing limb, and that by E13.5-14.5, these are predominantly located in the mesenchyme surrounding the senescent cells, suggesting that developmental senescent cells might also be removed by macrophage-mediated clearance ( Figure S6) .
Next, we costained SAb-gal sections with TUNEL to identify whether these cells might be undergoing apoptosis. At E11.5-12.5, only a small percentage of the senescent cells in the AER were apoptotic (Figures 6A, 6B, and 6E) . By E13.5 however, this percentage increased in both the ectoderm and the mesenchyme ( Figures 6C and 6E) , and by E14.5, almost all of the remaining senescent cells, now located in the interdigital mesenchyme, were apoptotic ( Figures 6D and 6E) . Interestingly, the clusters of immune cells surrounding the senescent cells also stained positive for TUNEL, presumably identifying macrophages containing apoptotic bodies ( Figures 6C and 6D) . At each stage, the number of apoptotic cells outnumbered the quantity of dying senescent cells, suggesting that there are separate populations of cells undergoing apoptosis at this stage. Altogether, this identifies that, at least in the AER, senescent cells undergo a coordinated process of redistribution to the interdigital mesenchyme, apoptosis, and macrophage-mediated clearance.
Senescence in the AER Is Instructed by Paracrine Signaling from the Underlying Stroma
The AER initiates through instructive signaling from the underlying mesenchyme. In turn, the established AER instructs proliferation through growth factor signaling, which activates phospho-ERK (pERK) pathways in the mesenchyme (Corson et al., 2003) . Reciprocally, the mesenchyme then maintains AER function, establishing interdependency of the two regions (Capdevila and Izpisú a Belmonte, 2001; Kanegae et al., 1998) . Surprisingly, adult stress-induced senescence is maintained in part by ERK signaling, with these growth-promoting signals paradoxically contributing to the arrested state. Given that senescence is synonymous with the AER, we asked whether it too might be mediated by signals arising from the mesenchyme. First, we determined pERK expression in the whole limb at E11.5, specifically detecting pERK only in the mesenchyme underlying the AER ( Figure 7A ) as previously demonstrated (Corson et al., 2003) . Next, we wanted to determine whether transient in vivo inhibition of ERK signaling could affect senescence. To address this, we injected pregnant females at E11.5 with the MEK inhibitor U0126, which prevents ERK phosphorylation in vivo and blocks OIS in the adult (Shukla et al., 2007) . Surprisingly, this led to a significant reduction of the number of senescent cells in the AER (Figure 7B ), suggesting that pERKmediated signaling in the mesenchyme establishes paracrine instruction of senescence in the AER. Next, to see whether prolonged inhibition of ERK signaling might have additional effects, we cultured E11.5 embryonic limbs for 15-24 hr in the presence of U0126 ( Figure 7C ). Remarkably, while control limbs developed normally and retained a normal pattern of senescence, inhibition of ERK signaling led to a significant loss of senescence in the AER concomitant with abnormal development of the limb. Together, this suggests that senescence is maintained in part via paracrine signals from the underlying mesenchyme, and that a deregulation of this process leads to developmental abnormalities.
DISCUSSION
Here we describe that senescence is a key feature of embryonic development and, importantly, identify senescent cells in a normal in vivo setting. We use chick and mouse models to show that senescence is a recurrent process in the embryo, is restricted to particular regions and structures, and follows a specific time course, identifying that developmental senescence is a conserved programmed mechanism. We used SAb-gal staining to identify senescent cells in the embryo because it is a proven and reliable marker of senescence in vivo in many settings, including premalignant lesions (Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005) , chemotherapy and tumor regression (Schmitt et al., 2002; Xue et al., 2007) , premature aging (Baker et al., 2011; Keyes et al., 2005) , fibrotic tissue (Jun and Lau, 2010; Krizhanovsky et al., 2008) , and aging human skin (Dimri et al., 1995) . Furthermore, in addition to the many regions identified here with a whole-mount staining approach, we believe that many other developing structures will also use senescence to mediate correct patterning at distinct stages of development, as exemplified in the accompanying manuscript (Muñ oz- Espín et al., 2013) .
Interestingly, we identified significant overlap between developmental and oncogene-induced senescence, including expression of p21, p15, and a number of SASP components (Kuilman et al., 2010) . Subsequently, to characterize developmental senescence, we focused on the AER and the RP. Interestingly, these are both major signaling centers in the embryo that instruct growth and patterning through the release of secreted factors and whose disruption can significantly perturb normal development (Chizhikov and Millen, 2004; Lee et al., 2000; Mariani et al., 2008) . Remarkably, in each case, the secreted proteins are common components of the SASP of adult stress-induced senescence, suggesting that some of the paradoxical functions of the SASP in OIS might involve a reactivation of developmental processes. Indeed, this common expression of key mediators and features suggests that senescence might primarily have arisen as a developmental mechanism that was later adapted during evolution to perform its adult roles.
However, there are also notable differences between developmental and adult senescence. Surprisingly, in senescent cells in the embryo, we failed to detect p16 or DNA damage, two central mediators of replicative and oncogene-induced senescence (Kuilman et al., 2010) . Additionally, mediators of senescent reinforcement such as interleukin-6 (IL-6) and IL-8 were also not increased in our array (Acosta et al., 2008; Kuilman et al., 2008) . One possible interpretation is that developmental senescence represents a more primitive form of senescence intended as a temporary signaling process during particular developmental stages, whereas the pathological aspects of OIS or aging necessitated the establishment of more complex regulation, requiring additional mediators of reinforcement (Kuilman et al., 2010) . More detailed comparisons of senescence in each condition will be informative in classifying stimulus-specific mediators, as well as identifying new common markers of senescence.
While we, and the accompanying study (Muñ oz-Espín et al., 2013) , identify p21 as one mediator of developmental senescence, precisely how p21 contributes to the regulation of developmental senescence remains to be determined. A member of the CIP/KIP family of cyclin-dependent kinase inhibitors, p21 is a potent inhibitor of proliferation and an important mediator of senescence (Xiong et al., 1993) . Despite primarily being regulated by p53 in stress-induced senescence, in the embryo, p21 function is p53 independent (Parker et al., 1995) . However, an additional feature of p21 is to protect from apoptosis, both at the intracellular level and through paracrine effects mediated by the secretion of survival/SASP factors (Chang et al., 2000; Devgan et al., 2006; Roninson, 2002) . Our data suggest that p21 contributes to many aspects of the senescent state, preventing proliferation and apoptosis, while regulating secretion of SASP factors. Interestingly, however, in OIS, p21 levels are not maintained and return to nearly normal levels as p16 increases to establish irreversibility (Alcorta et al., 1996) . As loss of p21 is associated with apoptosis in the limb mesenchyme (Vasey et al., 2011 and data not shown), this suggests that the p21-p16 expression juncture might represent a critical step in the senescence-apoptosis fate determination of cells.
Additionally, it might seem surprising that mice deficient in p21 do not have more pronounced developmental defects. However, embryos are particularly resilient and adaptive to alterations, often requiring compound deficiencies before a frank defect manifests, as in the case of the pRB-related p130 and p107 genes (Cobrinik et al., 1996) or FGF members in the AER (Mariani et al., 2008) . Alternatively, adaptations can arise, as seen in mice deficient in the proapoptotic mediator Apaf1, which present with a delayed mid-stage limb development that is ultimately resolved by birth (Yoshida et al., 1998) . Furthermore, whereas a deficiency of the hematopoietic lineage-specific transcription factor PU.1 prevents macrophage development, clearance of interdigital cell death is functionally replaced by mesenchymal cells adopting phagocytic properties (Wood et al., 2000) . In the absence of p21, it is possible that other family members such as p57 or senescence mediators like p15 might play similar compensatory roles (Zhang et al., 1999) .
Our study shows that, at least in the AER, senescent cells undergo a fate of cell death and immune-mediated clearance. The role of apoptosis and macrophage-mediated phagocytosis in interdigital cell death is well established, as is the immunemediated clearance of adult senescence (Kang et al., 2011; Wood et al., 2000; Xue et al., 2007) . However, whether senescent cells in the limb undergo apoptosis before clearance or macrophages directly induce apoptosis in the senescent cells remains to be shown (Lang and Bishop, 1993) . Nonetheless, it is interesting to note that macrophages are recruited to lie adjacent to the senescent AER prior to the appearance of cell death (Rae et al., 2007) , suggesting that a primary function of senescence is to contribute to the cellular balance of the tissue, recruiting macrophages to sites where they will ultimately be needed for phagocytosis. In addition, as embryonic macrophages can have trophic and patterning functions mediated by CSF1 instruction (Qian and Pollard, 2010; Rae et al., 2007) , it is tempting to speculate that developmental senescence might also indirectly contribute to tissue patterning.
Notably, this study uncovers the senescence program as an integral and inseparable component of limb biology, with disruption of the normal homeostatic signals through genetic or chemical means, leading to a loss of the senescent state. This introduces the question of the identity of senescence-inducing signals. We identify that a disruption of pERK signaling in the underlying mesenchyme perturbs normal senescence and development. Interestingly, Rel/NF-kB, a master regulator of OIS and the SASP, is expressed in the PZ and is required for proper AER maintenance, suggesting that this might be one such mediator of senescence instruction from the pERK-positive mesenchyme (Kanegae et al., 1998) . However, our data also suggest that the AER may be subject to autocrine or local-paracrine influence on the senescent state within the AER, involving CEBP/b, transforming growth factor b (TGF-b), and p15 pathways (Acosta et al., 2013; Gomis et al., 2006; Hannon and Beach, 1994) .
In summary, this study and the accompanying manuscript from Serrano and colleagues (Muñ oz-Espín et al., 2013) describe the identification of cellular senescence as a cellular process and an additional layer of regulation in the developing embryo. We focused on two main areas where senescence is detected, the AER and the RP. Interestingly, these are among the most frequently disrupted areas affected by developmental birth defects, implying that an investigation of the regulatory mechanisms of developmental senescence might shed new light on the causes of developmental abnormalities. Additionally, this discovery helps to reconcile known and paradoxical functions of senescent cells in the adult with their biological role in the embryo, firmly establishing the importance of cellular senescence as a distinct regulatory and instructive cellular mechanism.
EXPERIMENTAL PROCEDURES Animal Use and Genotyping
Mice were housed in accordance with the CEEA (Ethical Committee for Animal Experimentation) of the Government of Catalonia. The details and genetic models used are described in the Extended Experimental Procedures. Fertilized hen's eggs (Granja Gibert, Tarragona, Spain) were incubated at 38 C for specified times, and embryos were staged according to Hamburger and Hamilton (1992) .
Histological Analysis, Immunohistochemistry, and Immunofluorescence Embryos were fixed in 4% PFA for 3 hr at room temperature and washed in PBS, and tissues were processed for paraffin embedding and sectioning. Embryos for phospho-ERK (p44/42) immunostaining were fixed in EFA solution overnight at 4 C. Immunostaining was performed using standard procedures with a complete list of antibodies included in the Extended Experimental Procedures. Whole-mount SAb-gal was detected as previously described (Keyes et al., 2005) . Incubation with X-gal was restricted to 3 hr unless otherwise stated.
Culture and Infection of Human Lung IMR90 Fibroblasts IMR90 fibroblast cultures were established and infected with oncogenic-Ras as per standard procotols. p21 deficiency was achieved through infection of pooled siRNA constructs against p21 (Thermo Scientific). Sequences are provided in Table S3 .
Microarray Analysis
Individual AER and limb ectoderm was microdissected from E11.5 forelimbs. Samples from 2-3 mice were pooled for each replicate, for 3-4 replicates. Total RNA was isolated using an RNA-easy plus micro RNA extraction kit (QIAGEN). RNA was subsequently labeled and hybridized to Agilent 8x60, 1-color gene expression arrays, with a detailed description of the analysis and statistical methods in the Extended Experimental Procedures.
RT-qPCR and Real-Time qPCR Analysis
Total RNA from cells and embryonic tissues was purified using an RNA-easy micro RNA extraction kit (QIAGEN). Equal amounts of RNA were reversetranscribed using random hexamer priming and SuperScript III (Invitrogen). Real time qPCR was performed using gene-specific primers (sequences in Table S3 ) and a LightCycler 480 (Roche).
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